Chronic exposure to environmentally relevant levels of simvastatin disrupts zebrafish brain gene signalling involved in energy metabolism Abstract Simvastatin (SIM), a hypocholesterolaemic drug of the statins group, is among the most prescribed pharmaceuticals for the prevention of cardiovascular diseases. Several studies have shown that lipophilic statins, as SIM, are able to cross the blood-brain barrier and interfere with the energy metabolism of the central nervous system in humans and mammalian models. In fish and other aquatic organisms, the effects of SIM on the brain energy metabolism are unknown, particularly following exposure to low environmentally relevant concentrations. Therefore, the present study aimed at investigating the effects of SIM on gene signalling pathways involved in brain energy metabolism of adult zebrafish (Danio rerio) following a chronic exposure (90 days) to environmentally relevant SIM concentrations ranging from 8 ng/L to 1000 ng/L. Real-Time PCR was used to determine the transcript levels of several genes involved in different pathways of the brain energy metabolism (glut1b, gapdh, acadm, accα, fasn, idh3a, cox4i1, and cox5aa) and the findings here reported integrated well with the ecological and biochemical responses obtained in a parallel study. The results showed that SIM can modulate the transcription of key genes involved in the mitochondrial electron transport chain, in glucose transport and metabolism, in fatty acid synthesis and β-oxidation. Furthermore, SIM exposure led to a sex-dependent transcription profile for some of the studied genes. Overall, the present study shows, for the first time, that SIM can modulate gene regulation of key pathways involved in the energy metabolism in fish brain at environmentally relevant concentrations.